As US medtech heavyweights pour billions into bladder-control therapies for ageing populations, an Australian company is ...

Phagenesis, a commercial-stage company with a first-of-its-kind neuromodulation system to treat patients experiencing difficulty swallowing post-stroke, welcomed the 2026 Guideline for the Early ...

Boston Scientific (NYSE:BSX) announced today that it completed its previously announced acquisition of Nalu Medical.

Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.